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proteins that are presumed to mediate the many re-Cyclin’ Round the Cell with Rac
sponses regulated by Rac (Bishop and Hall, 2000), in-
cluding Cyclin D1 expression. Rac is activated by gua-
nine nucleotide exchange factors (GEFs), which
stimulate release of GDP and allow GTP to bind. Just
as there are many effectors for Rac, there are many
mechanisms to activate it. The mechanism delineatedNew insight into how integrins stimulate cell cycle
by Mettouchi et al. involves the GEF SOS, which theyprogression is provided by a recent paper showing
find is required for fibronectin to induce Rac activation.that Rac is activated in endothelial cells plated on
SOS was originally isolated as a GEF for Ras but has afibronectin, but not on laminin, and regulates transla-
separate Dbl-homology (DH) domain that acts as a Raction of Cyclin D1 mRNA.
GEF (Das et al., 2000). SOS GEF activity for Rac can be
activated by phosphatidylinositol (3,4,5)trisphosphateRac is a small GTPase with many facets and contributes
(Das et al., 2000), and consistent with this phosphoinosi-under different guises to diverse cellular responses. One
tide 3-kinase is required for Rac activation (Mettouchiaspect that has been studied extensively is that of actin
et al., 2001). In addition, focal adhesion kinase (FAK)
cytoskeleton regulator—Rac is well-known for its ability
and the adaptor protein Shc are required to link SOS
to stimulate actin polymerization at the plasma mem-
activation to integrin engagement. Previously, activation
brane to form lamellipodia. A more enigmatic facet is
of Rac by SOS was shown to require two other adaptor
that of cell cycle regulator: Rac has long been known
proteins, Eps8 and e3B1 (also known as Abl interactor-1
to contribute to cell cycle progression, along with its
or Abi-1) (Scita et al., 1999). Whether Eps8 and e3B1
close relatives Cdc42 and Rho, but how it does this at are also involved in the integrin-induced activation of
the molecular level is not clear. Cell cycle progression Rac by SOS and subsequent Cyclin D1 accumulation
requires expression of a number of cell cycle regulatory would be interesting to know.
genes, and there is a lot of evidence showing that Rac SOS is not the only method for integrins to activate
can regulate gene transcription (Bishop and Hall, 2000). Rac, however (see Figure). Integrins can also activate
The clearest link with the cell cycle is provided by studies Rac through Vav family GEFs, at least in some cell types,
showing that Rac can regulate the transcription of Cyclin including hematopoietic cells (Schwartz and Shattil,
D1 (Joyce et al., 1999), a key cell cycle regulator that 2000). Another route from integrins to Rac involves a
activates the cyclin-dependent kinases CDK4 and CDK6 complex of proteins including Crk, Cas, and DOCK180.
during the G1 phase of the cell cycle. However, it seems This pathway has been widely implicated in integrin-
unlikely that Rac’s contribution to cell cycle progression regulated cell migration and phagocytosis rather than
and cell transformation rests simply on increased tran- proliferation (Caron, 2000; Schwartz and Shattil, 2000).
scription of one gene. A paper by Mettouchi et al. in the In fact, Mettouchi et al. show that a dominant-negative
July issue of Molecular Cell provides new insight into Crk does not affect fibronectin-mediated Rac activation
Rac function: Rac can regulate cell cycle progression in their system, suggesting that the Crk/Cas/DOCK180
by stimulating translation of the Cyclin D1 message route to Rac is not involved here. Interestingly, when
(Mettouchi et al., 2001). In endothelial cells, this function assaying migration as an outcome of integrin signaling,
of Rac turns out to be critical for determining their re- laminin rather than fibronectin is a better activator of
sponsiveness to extracellular matrix proteins. On fibro- Rac in A459 cells, a lung carcinoma cell line, and this
nectin, Rac is activated and the cells enter the cell cycle, activation is dependent on Crk/Cas/DOCK180 (Gu et
whereas on laminin Rac is not activated and the cells al., 2001). This suggests that the molecular mechanism
remain quiescent. This difference in response is attrib- underlying integrin-induced Rac activation differs de-
uted to the engagement of different cell surface recep- pending on the conditions; undoubtedly, the integrin
tors: the 51 integrin for fibronectin and the 21 integ- expression profile of the cell type will affect this. Whether
rin for laminin. a GEF such as SOS plays a role in the Crk/Cas/DOCK180
Rac cycles between an active, GTP-bound conforma- route is not clear: DOCK180 can bind directly to Rac
tion and an inactive, GDP-bound conformation. When but does not contain a classic DH GEF domain (Caron,
2000).bound to GTP, it can interact with a multitude of effector
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Links between Integrins, Rac, and Down-
stream Responses
Examples of different signaling pathways
linking integrins to Rac are shown. First, Rac
activation by integrins can involve a complex
of Crk, DOCK180, and Cas. This leads to actin
cytoskeletal changes required for cell migra-
tion (e.g., A459 lung carcinoma cells) or
phagocytosis of apoptotic cells by macro-
phages/dendritic cells. Whether this pathway
involves a DH (Dbl-homology) family GEF for
Rac is not clear. Second, Rac activation can
be mediated by a complex of focal adhesion
kinase (FAK), Shc, and PI 3-kinase (PI3K),
which act on SOS, a DH family GEF. In endo-
thelial cells this pathway is required to induce
an increase in Cyclin D1 protein and cell cycle
progression. Finally, in hematopoietic cells
Rac can be activated by integrins via Syk and
Vav, a DH family GEF. This pathway can con-
tribute to both actin cytoskeletal changes and
cell cycle progression.
Once Rac is activated, why does it affect Cyclin D1 it seems unlikely that Rac’s contribution to cell cycle
progression lies solely in Cyclin D1. With the presenttranslation here, when previously it has been reported
to affect Cyclin D1 transcription? One difference be- explosion of microarray and proteomic analyses, it
should not be long before we have a more global picturetween this work (Mettouchi et al., 2001) and that of most
others working Rac and cell cycle progression is the of Rac’s contribution to gene expression.
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